Zacks Small Cap Analysis – MNOV: A number of Abstracts Introduced at 92nd EAS Congress… – Tech Cyber Internet
By David Bautz, PhD NASDAQ:MNOV READ THE FULL MNOV RESEARCH REPORT Enterprise Replace Abstracts Relating to MN-001 and MN-002 Introduced at 92nd EAS Congress On Could 28, 2024, MediciNova (NASDAQ:MNOV) introduced that two abstracts concerning MN-001 (tipelukast) and MN-002 have been offered as posters on the 92nd European Atherosclerosis Society (EAS) 2024 Congress. The poster … Read more
